BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24698324)

  • 1. MicroRNA-150 regulates the cytotoxicity of natural killers by targeting perforin-1.
    Kim N; Kim M; Yun S; Doh J; Greenberg PD; Kim TD; Choi I
    J Allergy Clin Immunol; 2014 Jul; 134(1):195-203. PubMed ID: 24698324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity.
    Kim TD; Lee SU; Yun S; Sun HN; Lee SH; Kim JW; Kim HM; Park SK; Lee CW; Yoon SR; Greenberg PD; Choi I
    Blood; 2011 Nov; 118(20):5476-86. PubMed ID: 21960590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of miR-30e regulating NK cell activities on immune tolerance of maternal-fetal interface by targeting PRF1.
    Huang Q; Ding J; Gong M; Wei M; Zhao Q; Yang J
    Biomed Pharmacother; 2019 Jan; 109():1478-1487. PubMed ID: 30551399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcriptional control of the perforin locus.
    Pipkin ME; Rao A; Lichtenheld MG
    Immunol Rev; 2010 May; 235(1):55-72. PubMed ID: 20536555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs.
    Fehniger TA; Cai SF; Cao X; Bredemeyer AJ; Presti RM; French AR; Ley TJ
    Immunity; 2007 Jun; 26(6):798-811. PubMed ID: 17540585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of resting and type I IFN-activated human NK cell miRNomes reveals microRNA-378 and microRNA-30e as negative regulators of NK cell cytotoxicity.
    Wang P; Gu Y; Zhang Q; Han Y; Hou J; Lin L; Wu C; Bao Y; Su X; Jiang M; Wang Q; Li N; Cao X
    J Immunol; 2012 Jul; 189(1):211-21. PubMed ID: 22649192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK Cells.
    Vicioso Y; Wong DP; Roy NK; Das N; Zhang K; Ramakrishnan P; Parameswaran R
    Front Immunol; 2021; 12():652786. PubMed ID: 33995369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repressing PU.1 by miR-29a∗ in NK cells of HCV patients, diminishes its cytolytic effect on HCV infected cell models.
    Elemam NM; Mekky RY; El-Ekiaby NM; El Sobky SA; El Din MA; Esmat G; Abdelaziz AI
    Hum Immunol; 2015 Sep; 76(9):687-94. PubMed ID: 26429314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
    Austin Taylor M; Bennett M; Kumar V; Schatzle JD
    J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-21 induces the functional maturation of murine NK cells.
    Brady J; Hayakawa Y; Smyth MJ; Nutt SL
    J Immunol; 2004 Feb; 172(4):2048-58. PubMed ID: 14764669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo.
    Grundy MA; Zhang T; Sentman CL
    Cancer Immunol Immunother; 2007 Aug; 56(8):1153-61. PubMed ID: 17160409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-140-3p inhibits natural killer cytotoxicity to human ovarian cancer via targeting MAPK1.
    Wang J; Zhu M; Zhou X; Wang T; Xi Y; Jing Z; Xi W
    J Biosci; 2020; 45():. PubMed ID: 32385217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perforin gene mutations in patients with acquired aplastic anemia.
    Solomou EE; Gibellini F; Stewart B; Malide D; Berg M; Visconte V; Green S; Childs R; Chanock SJ; Young NS
    Blood; 2007 Jun; 109(12):5234-7. PubMed ID: 17311987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3.
    Su Z; Ye X; Shang L
    Yonsei Med J; 2019 Jan; 60(1):22-29. PubMed ID: 30554487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of FCγR3A and PRF1 expression in peripheral blood mononuclear cells from patients with primary biliary cirrhosis.
    Li S; Ma D; Zhang L; Li X; Deng C; Qin X; Zhang T; Wang L; Shi Q; Wang Q; Wu Q; Zhang X; Zhang F; Li Y
    Dig Dis Sci; 2013 Feb; 58(2):458-64. PubMed ID: 23179144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct requirements for IFNs and STAT1 in NK cell function.
    Lee CK; Rao DT; Gertner R; Gimeno R; Frey AB; Levy DE
    J Immunol; 2000 Oct; 165(7):3571-7. PubMed ID: 11034357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygosity for the common perforin mutation, p.A91V, impairs the cytotoxicity of primary natural killer cells from healthy individuals.
    House IG; Thia K; Brennan AJ; Tothill R; Dobrovic A; Yeh WZ; Saffery R; Chatterton Z; Trapani JA; Voskoboinik I
    Immunol Cell Biol; 2015 Jul; 93(6):575-80. PubMed ID: 25776844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of natural killer cells with interleukin 2 (IL-2) and IL-12 increases perforin binding and subsequent lysis of tumour cells.
    Lehmann C; Zeis M; Uharek L
    Br J Haematol; 2001 Sep; 114(3):660-5. PubMed ID: 11552995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma.
    Abdelrahman MM; Fawzy IO; Bassiouni AA; Gomaa AI; Esmat G; Waked I; Abdelaziz AI
    Hum Immunol; 2016 Aug; 77(8):667-673. PubMed ID: 27262453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional impact of A91V mutation of the PRF1 perforin gene.
    Martínez-Pomar N; Lanio N; Romo N; Lopez-Botet M; Matamoros N
    Hum Immunol; 2013 Jan; 74(1):14-7. PubMed ID: 23073290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.